Evidence map›Paper›PMID 24412749›Full record

ArticleCellular signalling2014

Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.

Xuanzhi Zhan, Alejandro Perez, Luis E Gimenez, Sergey A Vishnivetskiy, Vsevolod V Gurevich

Abstract read
In one paragraph

Article in Cellular signalling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Arrestins as Possible Drug Targets.Biomolecules & therapeutics · 2025
    Review
  3. GPCR-dependent and -independent arrestin signaling.Trends in pharmacological sciences · 2024
    Review
  4. Arrestins: A Small Family of Multi-Functional Proteins.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.International journal of molecular sciences · 2022
    Article
  10. The Two Non-Visual Arrestins Engage ERK2 Differently.Journal of molecular biology · 2022
    Article
  11. Article
  12. Scaffolding of Mitogen-Activated Protein Kinase Signaling by β-Arrestins.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Targeting arrestin interactions with its partners for therapeutic purposes.Advances in protein chemistry and structural biology · 2020
    Review
  17. Review
  18. Article
  19. The structural basis of the arrestin binding to GPCRs.Molecular and cellular endocrinology · 2019
    Review
  20. Arrestin-3 scaffolding of the JNK3 cascade suggests a mechanism for signal amplification.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xuanzhi ZhanDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Alejandro PerezDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Luis E GimenezDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Sergey A VishnivetskiyDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Vsevolod V GurevichDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA. Electronic address: vsevolod.gurevich@vanderbilt.edu.
Vanderbilt University · US

Funding

STRUCTURE/FUNCTION STUDIES OF VISUAL ARRESTINR01EY011500 · NEI · VANDERBILT UNIVERSITY · PI T M Iverson · 1997 to 2026
$12.3M
Arrestin interactions with non-receptor binding partnersR01GM077561 · NIGMS · VANDERBILT UNIVERSITY · PI GUREVICH, VSEVOLOD V. · 2007 to 2015
$2.3M
Conformational regulation of arrestin-mediated signalingR01GM081756 · NIGMS · VANDERBILT UNIVERSITY · PI GUREVICH, VSEVOLOD V. · 2008 to 2011
$1.5M
NEI NIH HHS EY011500NEI NIH HHS R01 EY011500NIGMS NIH HHS GM077561NIGMS NIH HHS GM081756NIGMS NIH HHS R01 GM077561NIGMS NIH HHS R01 GM081756
6 · The paper itself

Abstract

Although arrestins bind dozens of non-receptor partners, the interaction sites for most signaling proteins remain unknown. Here we report the identification of arrestin-3 elements involved in binding MAP kinase JNK3α2. Using purified JNK3α2 and MBP fusions containing separated arrestin-3 domains and peptides exposed on the non-receptor-binding surface of arrestin-3 we showed that both domains bind JNK3α2 and identified one element on the N-domain and two on the C-domain that directly interact with JNK3α2. Using in vitro competition we confirmed that JNK3α2 engages identified N-domain element and one of the C-domain peptides in the full-length arrestin-3. The 25-amino acid N-domain element has the highest affinity for JNK3α2, suggesting that it is the key site for JNK3α2 docking. The identification of elements involved in protein-protein interactions paves the way to targeted redesign of signaling proteins to modulate cell signaling in desired ways. The tools and methods developed here to elucidate the molecular mechanism of arrestin-3 interactions with JNK3α2 are suitable for mapping of arrestin-3 sites involved in interactions with other partners.

Indexed as

AnimalsArrestinsBinding SitesChlorocebus aethiopsCOS CellsHumansMitogen-Activated Protein Kinase 10PhosphorylationProtein BindingProtein Interaction Domains and MotifsProtein Structure, TertiaryRecombinant Fusion ProteinsSignal Transductionarrestin3ArrestinsMitogen-Activated Protein Kinase 10Recombinant Fusion ProteinsArrestinJNK3MAP kinasesPhosphorylationProtein–protein interactions

Identifiers

PMID24412749
PMCPMC3936466
OpenAlexW2061244275

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.